The resident, identified as Resident #17 in inspection records, was prescribed Xarelto, a powerful anticoagulant medication used to prevent blood clots in patients with atrial fibrillation. The heart condition causes irregular beating that can allow blood to pool and form clots, dramatically increasing stroke risk.
Federal inspectors found nursing staff failed to complete required monitoring on multiple dates in August and September, despite physician orders dating back to June 2024 that specifically directed staff to watch for adverse reactions to the anticoagulant medication.
The resident's complex medical history made proper monitoring especially critical. Along with cerebral palsy and atrial fibrillation, the person suffered from chronic obstructive pulmonary disease, diabetes, schizophrenia, and high blood pressure. This combination of conditions can complicate anticoagulant therapy and increase the risk of both bleeding and clotting complications.
A physician order from February 24, 2025, prescribed Xarelto 20 mg tablets to be taken once daily in the morning specifically for the atrial fibrillation. The medication requires careful monitoring because it can cause serious bleeding complications while also preventing potentially fatal blood clots.
The facility's own care plan, initiated on June 27, 2025, explicitly directed staff to "monitor, document, and report to physician, as needed, signs and symptoms of anticoagulant complications." This plan recognized the inherent dangers of the medication and the need for vigilant oversight.
Yet when inspectors reviewed the Treatment Administration Record from July through September 2025, they found multiple gaps in monitoring. Staff failed to complete required checks on the evening shift of September 4 and on August 7, August 9, August 28, and August 29.
The missed monitoring sessions represented a pattern of neglect rather than isolated oversights. Each missed check increased the resident's vulnerability to undetected complications from the blood-thinning medication.
Signs and symptoms of anticoagulant complications can include unusual bruising, prolonged bleeding from minor cuts, blood in urine or stool, severe headaches, and unusual fatigue. Early detection of these warning signs is crucial for preventing life-threatening bleeding episodes.
When confronted by inspectors on September 11 at 9:35 AM, the Director of Nursing and another registered nurse acknowledged the failures. They stated the Treatment Administration Record should have been marked as completed on the dates in question, confirming that required monitoring had been skipped.
The admission revealed that nursing staff understood their obligations but had failed to fulfill them. The Director of Nursing's response suggested the monitoring requirements were clear but simply not followed.
For patients on anticoagulants like Xarelto, consistent monitoring is not optional paperwork but a critical safety measure. The medication works by interfering with the body's natural clotting mechanisms, creating a delicate balance between preventing dangerous clots and avoiding excessive bleeding.
Residents with multiple chronic conditions like Resident #17 face heightened risks from both the underlying diseases and the medications used to treat them. The cerebral palsy affects movement and balance, potentially increasing fall risk, while diabetes can complicate wound healing if bleeding occurs.
The facility's failure to follow its own care plan protocols demonstrates a breakdown in basic nursing oversight. Professional standards require nurses to complete ordered treatments and monitoring, not simply document them as complete when they have been skipped.
Federal inspectors classified the violation as causing minimal harm or potential for actual harm, but the consequences of unmonitored anticoagulant therapy can be severe. Residents have suffered fatal bleeding complications when warning signs went undetected.
The inspection found that few residents were affected by this particular deficiency, suggesting the monitoring failures were specific to Resident #17's care rather than a facility-wide problem with anticoagulant oversight.
The case illustrates how vulnerable residents depend entirely on nursing staff to follow medical orders that can mean the difference between stable health and medical crisis. When those basic protections fail, residents with complex conditions like Resident #17 face unnecessary risks that proper monitoring could prevent.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Timber Springs Transitional Care from 2025-09-12 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Timber Springs Transitional Care
- Browse all ID nursing home inspections